End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
26.34 CNY | -2.84% | +0.15% | -38.50% |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- Analysts covering this company mostly recommend stock overweighting or purchase.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 75.26 times its estimated earnings per share for the ongoing year.
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
Ratings chart - Surperformance
Sector: Semiconductors
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-38.50% | 247M | - | ||
+29.06% | 64.75B | B- | ||
-18.74% | 14.66B | B | ||
+20.50% | 11.77B | B+ | ||
+27.11% | 9.05B | B- | ||
+9.09% | 9.09B | B | ||
+40.60% | 8.21B | D+ | ||
-5.22% | 8.6B | B- | ||
-9.71% | 7.87B | B | ||
+26.33% | 6.35B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- 688045 Stock
- Ratings Shenzhen Kiwi Instruments Co., Ltd.